Market Overview

10 Biggest Mid-Day Losers For Thursday

Share:
  • DragonWave, Inc.(USA) (NASDAQ: DRWI) shares dropped 14.7 percent to $0.930. DragonWave reported a Q1 loss of $0.52 per share on revenue of $9 million.
  • XCel Brands Inc (NASDAQ: XELB) shares fell 8.8 percent to $3.10.
  • TESARO Inc (NASDAQ: TSRO) shares dropped 7.7 percent to $127.66. Tesaro’s sale process is unlikely to result in a deal, according to CNBC's David Faber.
  • Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares declined 7 percent to $12.25. Amicus Therapeutics reported a $225 million public offering of common stock.
  • Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares dipped 6.5 percent to $2.92. Catalyst Pharma announced a $150 million mixed securities shelf offering.
  • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares declined 6.4 percent to $23.75 after dropping 2.46 percent on Wednesday.
  • Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares dropped 5.2 percent to $5.63.
  • ARC Group WorldWide Inc (NASDAQ: ARCW) shares declined 5.2 percent to $2.75.
  • Seagate Technology PLC (NASDAQ: STX) shares fell around 4.6 percent to $37.87. Barclays downgraded Seagate from Equal-Weight to Underweight.
  • Silgan Holdings Inc. (NASDAQ: SLGN) dropped 3.2 percent to $31.11. Goldman Sachs downgraded Silgan from Neutral to Sell.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

 

Related Articles (ARCW + ARNA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ARMKBarclaysMaintains45.0
HDDZ BankDowngrades
COGWolfe ResearchUpgrades
MLHRSidoti & Co.Maintains45.0
ICFISidoti & Co.Maintains99.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Believe In The Haemonetics Turnaround Story; JMP Upgrades To Market Outperform

Cramer Questions Wedbush's Bearish Netflix Thesis